Abbott Accounts Payable from 2010 to 2024
ABT Stock | USD 118.95 0.99 0.84% |
Accounts Payable | First Reported 1989-12-31 | Previous Quarter 4.1 B | Current Value 4 B | Quarterly Volatility 1.2 B |
Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.4 B, Interest Expense of 605.1 M or Selling General Administrative of 6.2 B, as well as many indicators such as Price To Sales Ratio of 5.0, Dividend Yield of 0.0177 or PTB Ratio of 2.62. Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.
Abbott | Accounts Payable |
Latest Abbott Laboratories' Accounts Payable Growth Pattern
Below is the plot of the Accounts Payable of Abbott Laboratories over the last few years. An accounting item on the balance sheet that represents Abbott Laboratories obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Abbott Laboratories are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Abbott Laboratories' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abbott Laboratories' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable | 10 Years Trend |
|
Accounts Payable |
Timeline |
Abbott Accounts Payable Regression Statistics
Arithmetic Mean | 2,571,444,467 | |
Geometric Mean | 2,051,679,564 | |
Coefficient Of Variation | 58.84 | |
Mean Deviation | 1,332,351,831 | |
Median | 2,402,000,000 | |
Standard Deviation | 1,513,038,018 | |
Sample Variance | 2289284T | |
Range | 4.3B | |
R-Value | 0.92 | |
Mean Square Error | 376131.3T | |
R-Squared | 0.85 | |
Slope | 311,449,779 | |
Total Sum of Squares | 32049976.6T |
Abbott Accounts Payable History
About Abbott Laboratories Financial Statements
Abbott Laboratories shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may analyze each financial statement separately, they are all interrelated. The changes in Abbott Laboratories' assets and liabilities, for example, are also reflected in the revenues and expenses on on Abbott Laboratories' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last Reported | Projected for Next Year | ||
Accounts Payable | 4.3 B | 4.5 B |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.